← Leaderboards
Bryan David Bryson
Massachusetts General Hospital
$5,615,237
Attributed
$8,287,264
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,287,264 · 4
By mechanism
R01$6,187,264 · 3
R35$2,100,000 · 1
Top collaborators
- Joshua T. Mattila6 shared
- Cory Michael Robinson4 shared
- Christina Leigh Stallings2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Andre Jan Willem Van Der Kouwe$11,163,026
- Lindsay Tara Fourman$1,532,953
- Martha Holmes$950,962
- Mamadou Kaba$950,962
- Ernesta Maria Meintjes$4,925,944
Others in their field
Other Emerging Leaders on “Tissues”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$61,115,130
- Leonard Freedman · Leidos Biomedical Research, Inc.$54,559,980
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Evan Z Macosko · Broad Institute, Inc.$33,867,067
Research focus
TissuesImmuneMolecularMacrophageProgramsResponseCell TypeLinkTuberculosisAcuteAffectMycobacterium TuberculosisCellular BiologyMicrobiologyHigh DimensionalityInfectionHiv/TbPathogenPhagosomesExtracellularSeveritiesInsightEventExperimental Study
Grant awards (14)
Type I IFN-dependent and independent contributions to the outcomes of early innate immune cell interactions during HIV/TB co-infection$872,144
R01 · FY2025 · AI
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB$544,872
R01 · FY2025 · AI
High-dimensional characterization of phagosome composition, control and phagocytic receptor redundancy$420,000
R35 · FY2025 · GM · contact PI
Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children$911,002
R01 · FY2024 · AI · contact PI
Type I IFN-dependent and independent contributions to the outcomes of early innate immune cell interactions during HIV/TB co-infection$899,894
R01 · FY2024 · AI
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB$539,481
R01 · FY2024 · AI
High-dimensional characterization of phagosome composition, control and phagocytic receptor redundancy$420,000
R35 · FY2024 · GM · contact PI
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB$603,802
R01 · FY2023 · AI
High-dimensional characterization of phagosome composition, control and phagocytic receptor redundancy$420,000
R35 · FY2023 · GM · contact PI
Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children$316,760
R01 · FY2023 · AI · contact PI
Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children$951,462
R01 · FY2022 · AI · contact PI
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB$547,847
R01 · FY2022 · AI
High-dimensional characterization of phagosome composition, control and phagocytic receptor redundancy$420,000
R35 · FY2022 · GM · contact PI
High-dimensional characterization of phagosome composition, control and phagocytic receptor redundancy$420,000
R35 · FY2021 · GM · contact PI